LONDON/ZURICH (Reuters) – Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.
The Swiss drugmaker said on Sunday it would pay $74.00 a share through a tender...
Roche to buy U.S. biotech firm InterMune for $8.3 billion
Sunday, August 24, 2014
Roche to buy U.S. biotech firm InterMune for $8.3 billion
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment